Profile
Paul W.
Sandman served as an Independent Director at PDL BioPharma, Inc. from 2008 to 2020.
Prior to that, he was the Secretary, Executive VP & General Counsel at Boston Scientific Corp.
from 1993 to 2008 and the Secretary, Senior Vice President & General Counsel at Wang Laboratories, Inc. from 1981 to 1993.
Sandman received his undergraduate degree from Boston College and his graduate degree from Harvard Law School.
Former positions of Paul W. Sandman
Companies | Position | End |
---|---|---|
PDL BIOPHARMA, INC. | Director/Board Member | 2020-01-14 |
BOSTON SCIENTIFIC CORPORATION | General Counsel | 2008-02-28 |
Wang Laboratories, Inc.
Wang Laboratories, Inc. Information Technology ServicesTechnology Services Wang Laboratories, Inc. develops, markets, and supports software and provides integration and support services for computers. The company is based in Billerica, MA. Wang Laboratories was acquired by Getronics BV, part of Bottega InvestCo SARL from July 07, 2017 on June 08, 1999 for $1,376.08 million. | General Counsel | 1993-03-31 |
Training of Paul W. Sandman
Boston College | Undergraduate Degree |
Harvard Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Health Technology |
Private companies | 2 |
---|---|
Wang Laboratories, Inc.
Wang Laboratories, Inc. Information Technology ServicesTechnology Services Wang Laboratories, Inc. develops, markets, and supports software and provides integration and support services for computers. The company is based in Billerica, MA. Wang Laboratories was acquired by Getronics BV, part of Bottega InvestCo SARL from July 07, 2017 on June 08, 1999 for $1,376.08 million. | Technology Services |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Stock Market
- Insiders
- Paul W. Sandman